Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Non-renal-Related Mechanisms of FGF23 Pathophysiology.

Hanudel MR, Laster M, Salusky IB.

Curr Osteoporos Rep. 2018 Dec;16(6):724-729. doi: 10.1007/s11914-018-0492-2. Review.

PMID:
30353318
2.

Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.

Hanudel MR, Eisenga MF, Rappaport M, Chua K, Qiao B, Jung G, Gabayan V, Gales B, Ramos G, de Jong MA, van Zanden JJ, de Borst MH, Bakker SJL, Nemeth E, Salusky IB, Gaillard CAJM, Ganz T.

Nephrol Dial Transplant. 2018 Jul 10. doi: 10.1093/ndt/gfy189. [Epub ahead of print]

PMID:
30007314
3.

Clinical experience with the use of ferric citrate as a phosphate binder in pediatric dialysis patients.

Hanudel MR, Laster M, Ramos G, Gales B, Salusky IB.

Pediatr Nephrol. 2018 Nov;33(11):2137-2142. doi: 10.1007/s00467-018-3999-y. Epub 2018 Jun 28.

PMID:
29956006
4.

Levels of the erythropoietin-responsive hormone erythroferrone in mice and humans with chronic kidney disease.

Hanudel MR, Rappaport M, Chua K, Gabayan V, Qiao B, Jung G, Salusky IB, Ganz T, Nemeth E.

Haematologica. 2018 Apr;103(4):e141-e142. doi: 10.3324/haematol.2017.181743. Epub 2018 Feb 1. No abstract available.

5.

Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow.

Clinkenbeard EL, Hanudel MR, Stayrook KR, Appaiah HN, Farrow EG, Cass TA, Summers LJ, Ip CS, Hum JM, Thomas JC, Ivan M, Richine BM, Chan RJ, Clemens TL, Schipani E, Sabbagh Y, Xu L, Srour EF, Alvarez MB, Kacena MA, Salusky IB, Ganz T, Nemeth E, White KE.

Haematologica. 2017 Nov;102(11):e427-e430. doi: 10.3324/haematol.2017.167882. Epub 2017 Aug 17. No abstract available.

6.

Fractures and Osteomalacia in a Patient Treated With Frequent Home Hemodialysis.

Hanudel MR, Froch L, Gales B, J├╝ppner H, Salusky IB.

Am J Kidney Dis. 2017 Sep;70(3):445-448. doi: 10.1053/j.ajkd.2017.03.015. Epub 2017 May 9.

7.

Treatment of Pediatric Chronic Kidney Disease-Mineral and Bone Disorder.

Hanudel MR, Salusky IB.

Curr Osteoporos Rep. 2017 Jun;15(3):198-206. doi: 10.1007/s11914-017-0365-0. Review.

8.

Increased serum hepcidin contributes to the anemia of chronic kidney disease in a murine model.

Hanudel MR, Rappaport M, Gabayan V, Jung G, Salusky IB, Nemeth E, Ganz T, Zaritsky J.

Haematologica. 2017 Mar;102(3):e85-e88. doi: 10.3324/haematol.2016.150433. Epub 2016 Nov 24. No abstract available.

9.

Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.

Hanudel MR, Chua K, Rappaport M, Gabayan V, Valore E, Goltzman D, Ganz T, Nemeth E, Salusky IB.

Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1369-F1377. doi: 10.1152/ajprenal.00281.2016. Epub 2016 Oct 12.

10.

Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients.

Hanudel MR, Wesseling-Perry K, Gales B, Ramos G, Campbell V, Ethridge K, Scotti M, Elashoff DA, Alejos J, Reemtsen B, Salusky IB.

Pediatr Nephrol. 2016 Apr;31(4):661-9. doi: 10.1007/s00467-015-3257-5. Epub 2015 Nov 2.

11.

The accuracy of a continuous volumetric balancing system in pediatric continuous renal replacement therapy.

Hanudel MR, Salusky IB, Zaritsky JJ.

Int J Artif Organs. 2014 Mar;37(3):215-21. doi: 10.5301/ijao.5000296. Epub 2014 Apr 4.

12.

Corticosteroids in recurrence of glomerular disease in renal transplantation: do we know the right questions to ask?

Lau RL, Hanudel MR, Ettenger RB.

Pediatr Transplant. 2012 Nov;16(7):684-7. doi: 10.1111/j.1399-3046.2012.01776.x. Epub 2012 Sep 4. No abstract available.

PMID:
22943665

Supplemental Content

Loading ...
Support Center